Serum procalcitonin and proinflammatory cytokines in a patient with acute severe leptospirosis

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 1, 2000, Pages 104-105

  Petros, Sirak ^a   Leonhardt, Ute ^a   Engelmann, Lothar ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; HORMONE BLOOD LEVEL; HUMAN; LEPTOSPIROSIS; MALE;

EID: 0033969708     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540050164362     Document Type: Article

References (8)

1. Estavoyer JM, Racadol E, Couetdic G, Leroy J, Grosperrin L. Tumor necrosis factor in patients with leptospirosis [letter]. Rev Infect Dis 1991; 13: 1245-6.
2. Tajiki MH, Salomão R. Association of plasma levels of tumor necrosis factor α and with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis 1996; 23: 1177-8.
3. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
4. Al-Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996: 1: 331-3.
5. Lawrence EC, Holland VA, Young JB, Windsor NT, Brousseau KP, Noon GP, et al. Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantation. Am Rev Respir Dis 1989; 140: 789-96.
6. Nielson OH, Ciardelli T, Wu Z, Langholz E, Kirman I. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease. Am J Gastroenterol 1995; 90: 1301-6.
7. Moussa K, Michie HJ, Cree IA, McCafferty AC, Winter JH, Dhillon DP. et al. Phagocyte function and cytokine production in community acquired pneumonia. Thorax 1994; 49: 107-11.
8. Foley R, Couban S, Walker I, Greene K, Chen CS, Messner H. et al. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation. Bone Marrow Transplant 1998; 21: 769-73.